Effect of 90 Days Sub-chronic Administration of Omeprazole (A Proton Pump Inhibitor) on Haematological, Biochemical, Antioxidant, Reproductive and Histopathological Parameters in Male and Female Rats Cover

.blurhash-client-img { display: none !important; }

Effect of 90 Days Sub-chronic Administration of Omeprazole (A Proton Pump Inhibitor) on Haematological, Biochemical, Antioxidant, Reproductive and Histopathological Parameters in Male and Female Rats

Annals of Science and Technology

Volume 8 (2023): Issue 2 (December 2023)

By: Abidemi J. Akindele, Adedayo E. Oyerinde, Francis J. Olatoye and Adetutu O. Isinkaiye

Open Access

|Jan 2024

Authors

Abidemi J. Akindele

jakindele@unilag.edu.ng

Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria

Adedayo E. Oyerinde

Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria

Francis J. Olatoye

Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria

Adetutu O. Isinkaiye

Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria

DOI: https://doi.org/10.2478/ast-2023-0013 | Journal eISSN: 2544-6320

Journal RSS Feed

Language: English

Page range: 30 - 45

Submitted on: Jun 26, 2023

|

Accepted on: Aug 18, 2023

|

Published on: Jan 6, 2024

Published by: Sciendo

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Chronic toxicity,

Proton pump inhibitor,

Toxicological assessment

Related subjects:

Environmental chemistry,

Industrial chemistry,

Analytical Chemistry

© 2024 Abidemi J. Akindele, Adedayo E. Oyerinde, Francis J. Olatoye, Adetutu O. Isinkaiye, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 8 (2023): Issue 2 (December 2023)Next article